vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.
Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $17.3M, roughly 1.8× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 8.1%, a 59.2% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 4.8%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.
CHCT vs SLGL — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $17.3M |
| Net Profit | $2.5M | $11.6M |
| Gross Margin | — | — |
| Operating Margin | — | 65.1% |
| Net Margin | 8.1% | 67.3% |
| Revenue YoY | 4.8% | 217.7% |
| Net Profit YoY | 60.2% | 487.6% |
| EPS (diluted) | — | $4.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | — | ||
| Q3 25 | $31.1M | — | ||
| Q2 25 | $29.1M | $17.3M | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $29.3M | — | ||
| Q3 24 | $29.6M | — | ||
| Q2 24 | $27.5M | $5.4M |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $-12.6M | $11.6M | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $-10.4M | $2.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 65.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 29.9% |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | -43.2% | 67.3% | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | -37.9% | 36.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.50 | $4.17 | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.04 | — | ||
| Q2 24 | $-0.42 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $24.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $421.3M | $31.9M |
| Total Assets | $1.0B | $39.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | — | ||
| Q3 25 | $3.4M | — | ||
| Q2 25 | $4.9M | $24.3M | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $2.8M | — | ||
| Q2 24 | $734.0K | $26.5M |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | — | ||
| Q2 24 | $457.6M | — |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | — | ||
| Q3 25 | $426.8M | — | ||
| Q2 25 | $437.8M | $31.9M | ||
| Q1 25 | $461.3M | — | ||
| Q4 24 | $476.0M | — | ||
| Q3 24 | $477.2M | — | ||
| Q2 24 | $497.8M | $34.9M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | — | ||
| Q3 25 | $987.3M | — | ||
| Q2 25 | $966.3M | $39.3M | ||
| Q1 25 | $985.1M | — | ||
| Q4 24 | $992.6M | — | ||
| Q3 24 | $981.8M | — | ||
| Q2 24 | $983.2M | $42.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
